Related Experiment Videos
Stargardt's disease and fundus flavimaculatus
Archives of Ophthalmology (Chicago, Ill. : 1960)
|July 1, 1979
Summary
Stargardt disease and fundus flavimaculatus appear clinically indistinguishable, both presenting as autosomal recessive macular degeneration. This condition causes progressive vision loss, typically starting in youth but sometimes delayed until adulthood.
Area of Science:
- Ophthalmology
- Genetics
- Medical Research
Background:
- Stargardt disease and fundus flavimaculatus are often considered distinct diagnoses.
- Both conditions involve macular degeneration with autosomal recessive inheritance patterns.
Purpose of the Study:
- To investigate the clinical distinctions between Stargardt disease and fundus flavimaculatus.
- To characterize the progression and presentation of these related macular dystrophies.
Main Methods:
- Ophthalmoscopic examination of 67 patients diagnosed with Stargardt disease or fundus flavimaculatus.
- Psychophysical and electrophysiologic testing to assess retinal function.
- Longitudinal follow-up to track disease progression.
Main Results:
- No clear ophthalmoscopic distinctions were found between Stargardt disease and fundus flavimaculatus.
- The hallmark symptom is diminished central vision, with bilateral and symmetrical presentation.
- Onset typically occurs in the first or second decade, but can be delayed until the fourth or fifth decade.
- Tests indicated a localized, not generalized, retinal dystrophy.
- Initial visual acuity of 6/12 (20/40) or better in one third of patients progressed to 6/30 (20/100) - 6/60 (20/400) over time.
Conclusions:
- Stargardt disease and fundus flavimaculatus represent a single disease spectrum based on clinical presentation.
- The condition is a localized retinal dystrophy characterized by progressive central vision loss.